Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net cash position 2021
P/E ratio 2021
Net income 2022
Net cash position 2022
P/E ratio 2022
1 195 M
1 195 M
EV / Sales 2021
EV / Sales 2022
Nbr of Employees
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that targets...
Ratings of Kura Oncology, Inc.
All news about KURA ONCOLOGY, INC.
09/13 KURA ONCOLOGY : Corporate Presentation - September 2021
09/07 KURA ONCOLOGY : to Participate in Two Upcoming Investor Conferences
08/06 KURA ONCOLOGY : Credit Suisse Lowers Kura Oncology's PT to $40 from $42, Updates Model wit..
08/05 KURA ONCOLOGY : Q2 Earnings Snapshot
08/05 KURA ONCOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
08/05 KURA ONCOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements ..
08/05 Kura Oncology, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
08/05 KURA ONCOLOGY : Reports Second Quarter 2021áFinancial Results
08/04 KURA ONCOLOGY : to Participate in Wedbush PacGrow Healthcare Virtual Conference
07/29 Kura Oncology to Report Second Quarter 2021 Financial Results
07/29 KURA ONCOLOGY, INC. : Change in Directors or Principal Officers, Financial Statements and ..
07/29 Kura Oncology Appoints Helen Collins, M.D. to Board of Directors
07/29 Kura Oncology, Inc. Appoints Helen Collins, M.D. as Class II Director to its Board of D..
07/06 KURA ONCOLOGY : to Collaborate With Novartis on Drug Combination for Head and Neck Squamou..
07/06 Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination wi..
News in other languages on KURA ONCOLOGY, INC.
- No features available -
Analyst Recommendations on KURA ONCOLOGY, INC.
Chart KURA ONCOLOGY, INC.
Technical analysis trends KURA ONCOLOGY, INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target